Bright Path Labs chosen as a collaborator in a first-ever National Science Foundation Engines Award
Bright Path is proud to have been chosen to collaborate with the The Puerto Rico Science, Technology, & Research Trust in a $1M NSF Innovation Engines Development Award
Bright Path Labs expands Board of Directors – Marc Fasteau
Vice-Chairman of the Coalition for a Prosperous America. Bright Path Labs has appointed Mr. Marc Fasteau as an independent director. Tony Quinones, CEO of BPL, stated, "We are extraordinarily honored and pleased that Mr. Fasteau has elected to join our board as an...
How will Quartic’s partnership with Bright Path Labs expand its presence in the life sciences?
Bright Path Labs has a technology that brings speed to the commercialization of API production. Continuous manufacturing is a big need in the pharmaceutical sector and Bright Path lab's technology accelerates that process. In order to enable and commercialize the...
Bright Path Laboratories selects TrackWise Digital QMS
Sparta Systems, provider of Quality Management System (QMS) platforms TrackWise and TrackWise Digital, has announced that Bright Path Laboratories, a leader in continuous-flow reactor technology, has selected TrackWise Digital as their QMS of the future. Bright Path...
Quartic.ai and Bright Path Labs partner on AI-powered continuous manufacturing
Quartic.ai, a manufacturing AI and IIoT platform supplier, and Bright Path Laboratories, a provider of continuous flow reactor technologies, have signed an agreement to develop an AI-powered continuous manufacturing platform for active pharmaceutical ingredients...
Bright Path Laboratories Develops New Way to Produce Active Pharmaceutical Ingredients
Bright Path Laboratories, Inc. (privately held) 3-year-old startup contract manufacturer – with offices in both Charlotte and Santa Fe, N.M. – recently got a strong show of support from The U.S. Food and Drug Administration for its patented spinning-tube-in-tube (STT)...
Contract Pharma Reports, Bright Path Labs Accepted into FDA’s Emerging Technology Program
Bright Path Laboratories, Inc. (BPL), a provider of continuous flow reactor technology, was accepted into the FDA's Emerging Technology Program, paving the way for the company to provide its low-cost and scalable technology to the domestic API manufacturing sector....
Medicine-for-All Institute (VCU) selects BPP as First Commercial Manufacturing Partner
RICHMOND, VA Bright Path Pharmaceuticals, LLC (privately held) today announced that the Medicines for All Institute, a joint venture between Virginia Commonwealth University and the Gates Foundation, has selected BPP as its' first commercial innovation manufacturing...
ChemWerth’s Dr. Xiping Su joins BPP’s Board
RICHMOND, VA Bright Path Pharmaceuticals, LLC (privately held), today announced that ChemWerth's Chief Scientific Officer, Dr. Xiping Su, has joined the Board of the company following their investment in BPP. Xiping Su, Ph.D., is organic chemistry and ChemWerth’s head...
Todd N. Smith joins BPP Board
CHARLOTTE, NC Bright Path Pharmaceuticals, LLC (privately held) today announced that Todd N. Smith, Chairman and CEO of Novum Pharma will join the Board. Mr. Smith has twenty-five years of pharmaceutical, medical device and biotechnology general management experience...